07:00 , Apr 17, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Inflammation

Indication Target/marker/pathway Summary Licensing status Publication and contact information Inflammation Asthma Potassium channel Kv1.3 (KCNA3) Rat studies suggest KCNA3 antagonists could be useful for treating asthma. In a rat model of allergen-induced asthma, injection of...